‘Personalised’ cancer treatment facilities growing
The pace of scientific research in the global development of new cancer treatments is astonishing, with precision medicines dramatically improving survivability rates; these have doubled since 1970. Immuno-oncology therapies empower the immune system to recognise and react to tumour cells, and biomarkerguided therapies target the mutation in tumour cells at a molecular level, in effect